• Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
  • Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
  • Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
  • Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
  • Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
  • Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg

Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg

Powder: No
Customized: Customized
Certification: GMP, Copp
Suitable for: Adult
State: Solid
Purity: >99%
Samples:
US$ 80/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory, Trading Company
Gold Member Since 2024

Suppliers with verified business licenses

Jiangxi, China
Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (17)

Basic Info.

Model NO.
ANTI-12-01
Transport Package
Level 3
Specification
875MG+125MG, 7′S*2/BOX
Trademark
Serumpharm
Origin
China
HS Code
2901231000

Product Description

AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET 875MG+125MG

Specification: 875MG+125MG,7'S*2/BOX
Trademark: Serumpharma
Support OEM/ODM: Yes
Mini. Order: 70000 Boxes
Delivery Time: 30~60 Days
Trade Term: FOB,CIF
Payment Term: T/T,L/C
Standard Available: CP,BP
Documents: GMP,COPP,CTD


Indicatios:
Amoxicillin and Clavulanate Potassium Tablets is indicated for the treatment of the following infections in adults and children:
• Acute bacterial sinusitis (adequately diagnosed)
• Acute otitis media
• Acute exacerbations of chronic bronchitis (adequately diagnosed)
• Community acquired pneumonia
• Cystitis
• Pyelonephritis
• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
• Bone and joint infections, in particular osteomyelitis.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Dosage and administration:
For adult dose:
One Amoxicillin and Clavulanate Potassium Tablet per 12h.
Pediatric Patients
Pediatric patients weighing 40 kg or more should be dosed according to the adult commendations.
The Amoxicillin and Clavulanate Potassium Tablets should not be used until the pediatric patient weighs at least 40 kg or more.
If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of Amoxicillin and Clavulanate Potassium Tablets is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid.
The duration of therapy should be determined by the response of the patient.  Some infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review .
Contraindications:
Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid.
Precautions:
Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents .
Convulsions may occur in patients with impaired renal function or in those receiving high doses (see section 4.8).
Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.
Prolonged use may occasionally result in overgrowth of non-susceptible organisms.
Periodic assessment of organ system functions, including renal, hepatic and haematopoietic function is advisable during prolonged therapy.
In patients with renal impairment, the dose should be adjusted according to the degree of impairment.
Drug interactions:
Oral anticoagulants
If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin.
Methotrexate
Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.
Probenecid
Concomitant use of probenecid is not recommended.   Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.
Mycophenolate mofetil
In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid (MPA) of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. Close clinical monitoring should be performed during the combination and shortly after antibiotic treatment.
Storage:
Store in the original package in order to protect from light.
Do not store above 25°C.

 

Amoxicillin and Clavulanate Potassium Tablet 875mg+125mg
Jiangxi Serum Pharma Industries Co.,Ltd. is a professional medical and pharmaceutical products supplier in China. We have been focused on exporting Biological products,Vaccines,Western medicines, APIs, Intermediates and medical products over 10 years, accumulating a wealth of experience. Our products have been exported to more than 30 countries, mainly in Asia, Africa, South America, Middle East and Europe, such as Philippines, Bangladesh,Laos,Cambodia, Kyrghyzstan, Cameroon, Guinea, Nigeria, Liberia, Mali, Yemen, Turkey, Chile, Australia and so on.Our finished products have won great popularity with reliable quality and competitive price,we have numerous end-users and good market reputation. 

We have developed advanced into the leading enterprise in pharmaceutical overseas exporting industry after years of efforts.Our products, including API and finished formulation, have been accredited with various certificates, such as Chinese GMP certificate, ISO9001 quality certificate.

The company has established close cooperation relations with domestic manufacturers of biological products, vaccines, raw material medicines and auxiliary materials, and has shared resources and complementary advantages. we are committed to the development and penetration of the international market and provide customers with quality assurance. We provide various pharmaceutical APIs and finished products with top quality at reasonable price and better after-sales service.

Our company has established a perfect quality assurance system in strict accordance with China's GMP requirements. The entire process from raw material procurement to finished product shipment is controlled by the quality assurance department.All raw materials are provided by selected reliable suppliers and carefully inspected by the Quality Assurance Department before use.

Excellence, Professionalism, and integrity are our cultures. We will offer good quality products with competitive prices and fast delivery for our customers. We are looking forward to setting up long-term cooperation relationship with you.
Amoxicillin and Clavulanate Potassium Tablet 875mg+125mgAmoxicillin and Clavulanate Potassium Tablet 875mg+125mgAmoxicillin and Clavulanate Potassium Tablet 875mg+125mgAmoxicillin and Clavulanate Potassium Tablet 875mg+125mgAmoxicillin and Clavulanate Potassium Tablet 875mg+125mg



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2024

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Management System Certification
ISO 9001, GMP, ISO 13485
OEM/ODM Availability
Yes